Supervivencia en pacientes con cáncer de mama triple negativo con enfermedad residual post-neoadyuvancia tratadas con capecitabine adyuvante

Supervivencia en pacientes con cáncer de mama triple negativo con enfermedad residual post-neoadyuvancia tratadas con capecitabine adyuvante

Antecedentes: La escasez de terapias eficaces ha contribuido a que el cáncer de mama triple negativo tenga resultados desfavorables. Objetivo: Evaluar supervivencia global y libre de progresión en pacientes con cáncer de mama triple negativo con enfermedad residual postneoadyuvancia, tratadas con...

Full description

Saved in:

Bibliographic Details
Main Authors:	Arnon J. Oviedo-Tábora, Elsa M. Vásquez-Trespalacios, Fernanda X. Bravo-Muñoz, Javier M. Cuello-Lopez
Format:	Article
Language:	Spanish
Published:	Sociedad de Lucha contra el Cáncer-SOLCA 2024-08-01
Series:	Oncología
Subjects:	triple-negative breast cancer Capecitabine ARB residual disease disease free survival overall survival
Online Access:	https://roe.solca.med.ec/index.php/johs/article/view/745
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Supervivencia en pacientes con cáncer de mama estadio IV inicial con manejo sistémico y quirúrgico
by: Fernanda Bravo, et al.
Published: (2024-04-01)

IMMEDIATE RESPONSE TO NEOADJUVANT CHEMOTHERAPY INCLUDING CAPECITABINE AND LONG-TERM TREATMENT OUTCOMES OF OPERABLE BREAST CANCER
by: E. M. Slonimskaya, et al.
Published: (2016-07-01)

Efficacy of adjuvant capecitabine in triple-negative breast cancer with residual disease after neoadjuvant therapy: a real-world study
by: Youzhao Ma, et al.
Published: (2025-06-01)

Supervivencia del paciente cirrótico con gastropatía portal hipertensiva
by: Marlén Pérez Lorenzo, et al.

Clinical pharmacokinetics of capecitabine and its metabolites in colorectal cancer patients
by: Saeed Alqahtani, et al.
Published: (2022-05-01)

CAPECITABINE IN THE TREATMENT OF BRAIN METASTATIC LESION IN PATIENTS WITH BREAST CANCER
by: E. A. Moskvina, et al.
Published: (2015-04-01)

Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21)
by: Jieun Lee, et al.
Published: (2025-08-01)

Adherence and safety study in patients on treatment with capecitabine
by: Francisca Fernández-Ribeiro, et al.
Published: (2017-03-01)

DETERMINATION OF CAPECITABINE AND ITS ACTIVE METABOLITE 5-FLUOROURACIL IN BLOOD PLASMA BY HPLC-MS/MS
by: E. S. Melnikov, et al.
Published: (2019-01-01)

Oxaliplatin combined with capecitabine therapy and comprehensive nursing in advanced colorectal cancer patients
by: Dan Kuang, et al.
Published: (2025-07-01)

Dupilumab for management of capecitabine-induced hand-foot syndrome
by: Ian Nykaza, BS, et al.
Published: (2025-09-01)

Development of an Early-Warning Model for Predicting the Capecitabine-Induced Diarrhea
by: Liu Z, et al.
Published: (2025-06-01)

Assessing the threat: Antibiotic resistant bacteria near Pittsburgh hospitals.
by: Frankel, B.
Published: (2022-08-01)

ACUTE MYOCARDIAL INFARCTION IN THE ABSENCE OF CORONARY ARTERY OBSTRUCTION – A COMPLICATION OF ANTICANCER THERAPY WITH CAPECITABINE
by: E. A. Kolomiets, et al.
Published: (2017-12-01)

Incidence of myocardial ischemia during treatment with capecitabine: a cohort study with Holter recording and cardiac biomarkers
by: Anne Dyhl-Polk, et al.
Published: (2025-07-01)

Immediate and long-term results of radiation therapy in combination with capecitabine and oxaliplatin in the treatment of patients with asquamous cell carcinoma of the anus
by: A. A. Nevolskikh, et al.
Published: (2023-09-01)

Disturbance of bile acids profile aggravates the diarrhea induced by capecitabine through inhibiting the Wnt/β-catenin pathway
by: Zhipeng Wang, et al.
Published: (2025-06-01)

Características clínicas y ecocardiográficas de cardiotoxicidad precoz en pacientes con cáncer de mama tratadas con quimioterapia
by: Julio Alberto Pérez Domínguez, et al.
Published: (2022-08-01)

Cost-effectiveness analysis of capecitabine versus active monitoring in stable or responding metastatic colorectal cancer after 16 weeks of first-line therapy
by: Tong Liu, et al.
Published: (2025-12-01)

Comparative study of low dose of capecitabine versus standard dose in metastatic breast cancer: Efficacy and safety
by: Aboelnaga Engy M, et al.
Published: (2021-08-01)

The Effect of Topical Heparin Gel on Reducing Hand–Foot Syndrome Symptoms in Cancer Patients Treated with Capecitabine
by: Maede Mirjalili, et al.

Differential expression of capecitabine-related metabolic enzymes in hepatocellular carcinoma and its clinical value: a retrospective cohort study
by: Jianing Lu, et al.
Published: (2025-06-01)

Cetuximab-Taxanes-Platinum-Fluorouracil/Capecitabine (C-TPF/C-TPX) – a Feasible Option for Recurrent HNSCC with Negative Prognostic Factors. Literature Review with a Case Presentation
by: Camil Ciprian MIRESTEAN, et al.
Published: (2023-03-01)

Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive patients) for patients with stage II or III breast cancer
by: Frankie Ann Holmes, et al.
Published: (2018-06-01)

A Case Report Capecitabine-Induce Grade II Hand and Foot Syndrome
by: Nurul Damayanti, et al.
Published: (2025-07-01)

Case report: A case of severe capecitabine toxicity due to confirmed in trans compound heterozygosity of a common and rare DPYD variant
by: Amy de Haar-Holleman, et al.
Published: (2024-09-01)

Lanolin-based dexpanthenol cream, topical hydrocortisone or observation in the prevention of capecitabine-induced hand-foot syndrome: a phase III trial
by: Cintia Sayuri Kurokawa La-Scala, et al.
Published: (2022-12-01)

Comparative Analysis of Clinical Efficacy and Safety of Pyrotinib Plus Capecitabine versus Trastuzumab Emtansine (T-DM1) as Second-Line Treatment for HER2-Positive Advanced Breast Cancer: A Retrospective Study
by: Han H, et al.
Published: (2025-04-01)

Case Report: Cardiotoxicity of capecitabine may manifest as STEMI with significant left ventricular cardiac dysfunction and recurrent supraventricular and ventricular arrhythmias: a proposal for optimal diagnosis and treatment
by: Sebastian Szmit, et al.
Published: (2025-06-01)

Docetaxel, Oxaliplatin with Capecitabine (TEX Regimen) in Metastatic Gastric and Gastroesophageal Adenocarcinoma: A Prospective Single-Arm Observational Study from a Tertiary Cancer Center in Kashmir
by: Sanudev Sadanandan Vadakke Puthiyottil, et al.
Published: (2025-04-01)

Drug Delivery by Carbon Nano Carrier for Use as Capecitabine Drug Carrier: A QM/MM study
by: Fahimeh Najafi
Published: (2025-01-01)

Psoriasis ostrácea con artritis psoriática tratada con infl iximab
by: Christian Burbano, et al.
Published: (2019-02-01)

Effect of Extra-Virgin Olive Oil on Hand Foot Syndrome and hs-CRP in Patients Receiving Capecitabine: A Randomized Trial
by: Yenny Dian Andayani, et al.
Published: (2024-01-01)

Squamous Cell Cancer of the Skin in a Patient on Maintenance Capecitabine for Metastatic Breast Cancer: A Case Report
by: Sidharth Mahajan, et al.
Published: (2024-09-01)

Improving the effectiveness of anticancer properties of capecitabine using aminocaproic acid-hyaluronic acid/sulfonamide IR-MOF nanoplatform for colon cancer treatment
by: Sedigheh Alavinia, et al.
Published: (2025-06-01)

Short-term efficacy and safety of sintilimab combined with oxaliplatin and capecitabine as neoadjuvant therapy for locally advanced gastric cancer
by: ZHANG Shuai, LIU Liangliang, HUANG Di, SHENG Ru, DU Xuetao, LI Shuguang, HU Nan, ZHAO Yifeng
Published: (2025-01-01)

Desempeño de juveniles del pez ángel Pterophyllum scalare alimentados con el oligoqueto Enchytraeus buchholzi
by: Jhon Edison Jiménez-Rojas
Published: (2012-04-01)

Clinical and Survival Insights into Carcinoma Penis: A Retrospective Analysis at a Tertiary Care Facility
by: Santosh Kumar Swain, et al.

Elefantiasis verrucosa nostra tratada con tazaroteno tópico
by: Luz Adriana Vásquez, et al.
Published: (2019-02-01)

Survival of retinoblastoma patients: a cohort study by two Russian medical centers
by: S. V. Saakyan, et al.
Published: (2021-03-01)